Lexington Biosciences, Inc.
OTC: LXGTF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Specialties
- CEO
- Donald Arthur McInnes
- Employees
- 543
- Headquarters
- Vancouver, Canada
- IPO year
- 2017
- Market cap
- $379.0
- Website
- https://www.lixiangedu.com
Loading LXGTF…
Loading profile data…Frequently asked questions about LXGTF
What does Lexington Biosciences, Inc. (LXGTF) do?
Registered Plan Private Investments Inc. operates as a private investment platform company. Its platform allows investors to use their registered plans, including registered retirement savings plans, registered education savings plans, tax-free savings accounts, registered retirement income funds, and registered disability savings plans at their...
Where does LXGTF trade?
Lexington Biosciences, Inc. (LXGTF) trades on the Other OTC.
What sector is LXGTF in?
Lexington Biosciences, Inc. (LXGTF) operates in the Healthcare sector, specifically in the Medical - Specialties industry.
Who is the CEO of Lexington Biosciences, Inc.?
Donald Arthur McInnes is the chief executive officer of Lexington Biosciences, Inc. (LXGTF).
Where is Lexington Biosciences, Inc. headquartered?
Lexington Biosciences, Inc. is headquartered in Canada.
Does LXGTF pay a dividend?
Lexington Biosciences, Inc. (LXGTF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did LXGTF go public?
Lexington Biosciences, Inc. (LXGTF) completed its initial public offering in 2017.